Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Intellipharmaceutics International Inc. IPCIF

Full chart Compare
Set alert

Price alert · IPCIF

All alert types
0.15 0.00 (+0.00%)

Nov 25, 2024, 3:00 PM EST

0.15 Day range 0.15

52-week range unavailable

Financial health

Altman Z-Score

-109.51 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.8×
FY 2014: -6.7×FY 2015: -17.2×FY 2016: -6.7×FY 2017: -7.3×FY 2018: -3.0×FY 2019: -0.1×FY 2020: -0.9×FY 2021: -0.6×FY 2022: -1.2×FY 2023: -0.8×
FY 2014 5y median -0.8× FY 2023
P/S 35.2×
FY 2014: 50.7×FY 2015: 7.6×FY 2016: 12.2×FY 2017: 33.2×FY 2018: 4.8×FY 2019: 0.9×FY 2020: 2.3×FY 2021: 2.2×FY 2022: 53.7×FY 2023: 35.2×
FY 2014 5y median 2.3× FY 2023
P/B -0.2×
FY 2014: -13.0×FY 2015: 13.5×FY 2016: -363×FY 2017: 66.7×FY 2018: 68.2×FY 2019: 0.4×FY 2020: -0.5×FY 2021: -0.4×FY 2022: -0.3×FY 2023: -0.2×
FY 2014 5y median -0.3× FY 2023
P/FCF -1.7×
FY 2014: -11.0×FY 2015: -26.7×FY 2016: -11.8×FY 2017: -11.0×FY 2018: -3.3×FY 2019: -0.1×FY 2020: 29.9×FY 2021: -1.2×FY 2022: -2.5×FY 2023: -1.7×
FY 2014 5y median -1.2× FY 2023
EV/EBITDA -1.7×
FY 2014: -12.3×FY 2015: -20.2×FY 2016: -7.4×FY 2017: -7.6×FY 2018: -3.3×FY 2019: -5.4×FY 2020: 10.2×FY 2021: 10.1×FY 2022: 22.1×FY 2023: -1.7×
FY 2014 5y median 10.1× FY 2023
EV/Sales 69.4×
FY 2014: 51.6×FY 2015: 7.3×FY 2016: 12.1×FY 2017: 32.0×FY 2018: 4.7×FY 2019: -1.9×FY 2020: 3.7×FY 2021: 3.0×FY 2022: 87.8×FY 2023: 69.4×
FY 2014 5y median 3.7× FY 2023
FCF Yield -59.9%
FY 2014: -9.1%FY 2015: -3.7%FY 2016: -8.4%FY 2017: -9.1%FY 2018: -30.1%FY 2019: -802.4%FY 2020: 3.3%FY 2021: -80.5%FY 2022: -39.3%FY 2023: -59.9%
FY 2014 5y median -59.9% FY 2023

Profitability

Gross Margin 100.0%
FY 2014: -232.3%FY 2015: 8.5%FY 2016: -77.0%FY 2017: -263.5%FY 2018: 87.2%FY 2019: 92.7%FY 2020: 97.6%FY 2021: 69.3%FY 2022: -290.2%FY 2023: 100.0%
FY 2014 5y median 92.7% FY 2023
Operating Margin -4336.8%
FY 2014: -446.4%FY 2015: -40.3%FY 2016: -173.8%FY 2017: -438.4%FY 2018: -150.2%FY 2019: -778.1%FY 2020: -333.8%FY 2021: -297.8%FY 2022: -4336.8%FY 2023: -4336.8%
FY 2014 5y median -778.1% FY 2023
Net Margin -4400.6%
FY 2014: -752.6%FY 2015: -44.0%FY 2016: -181.7%FY 2017: -451.4%FY 2018: -162.4%FY 2019: -802.2%FY 2020: -241.9%FY 2021: -367.1%FY 2022: -4400.6%FY 2023: -4400.6%
FY 2014 5y median -802.2% FY 2023
ROE 27.3%
FY 2014: 193.0%FY 2015: -78.6%FY 2016: 5401.0%FY 2017: -908.7%FY 2018: -2313.1%FY 2019: -334.9%FY 2020: 53.7%FY 2021: 63.1%FY 2022: 27.3%FY 2023: 27.3%
FY 2014 5y median 27.3% FY 2023
ROIC 34.5%
FY 2014: -417.9%FY 2015: -55.6%FY 2016: -454.0%FY 2017: -186.3%FY 2018: -204.6%FY 2019: -167.4%FY 2020: 111.4%FY 2021: 65.4%FY 2022: 34.5%FY 2023: 34.5%
FY 2014 5y median 34.5% FY 2023
ROA -202.0%
FY 2014: -262.5%FY 2015: -49.0%FY 2016: -142.3%FY 2017: -127.2%FY 2018: -120.8%FY 2019: -119.7%FY 2020: -100.1%FY 2021: -245.4%FY 2022: -202.0%FY 2023: -202.0%
FY 2014 5y median -202.0% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2014: 1326.3%FY 2015: 474.1%FY 2016: -53.3%FY 2017: -45.1%FY 2018: 145.0%FY 2019: -68.9%FY 2020: -18.2%FY 2021: 0.0%FY 2022: -95.3%FY 2023: 0.0%
FY 2014 FY 2023
Operating Income 0.0%
FY 2014: 32.6%FY 2015: 48.2%FY 2016: -101.4%FY 2017: -38.5%FY 2018: 16.1%FY 2019: -61.2%FY 2020: 64.9%FY 2021: 10.8%FY 2022: 31.7%FY 2023: 0.0%
FY 2014 FY 2023
EPS (diluted) 11.1%
FY 2014: -64.0%FY 2015: 71.4%FY 2016: -87.4%FY 2017: -21.4%FY 2018: 24.2%FY 2019: 0.0%FY 2020: 94.4%FY 2021: -37.5%FY 2022: 55.3%FY 2023: 11.1%
FY 2014 FY 2023
Free Cash Flow 0.0%
FY 2014: 18.9%FY 2015: 64.8%FY 2016: -69.6%FY 2017: -60.7%FY 2018: -17.1%FY 2019: -59.0%FY 2020: 100.9%FY 2021: -2377.7%FY 2022: 43.7%FY 2023: 0.0%
FY 2014 FY 2023

Financial Health

Current Ratio 0.0×
FY 2014: 1.0×FY 2015: 2.0×FY 2016: 0.6×FY 2017: 1.4×FY 2018: 0.8×FY 2019: 1.6×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 0.1× FY 2023
Quick Ratio 0.0×
FY 2014: 0.9×FY 2015: 2.0×FY 2016: 0.6×FY 2017: 1.5×FY 2018: 0.7×FY 2019: 1.6×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 0.1× FY 2023
Debt / Equity -0.2×
FY 2014: -0.4×FY 2015: 0.3×FY 2016: -11.3×FY 2017: 1.4×FY 2018: 3.3×FY 2019: 0.4×FY 2020: -0.3×FY 2021: -0.2×FY 2022: -0.2×FY 2023: -0.2×
FY 2014 5y median -0.2× FY 2023
Net Debt / EBITDA -0.8×
FY 2014: -0.2×FY 2015: 0.9×FY 2016: 0.0×FY 2017: 0.3×FY 2018: 0.1×FY 2019: -7.9×FY 2020: 3.8×FY 2021: 2.8×FY 2022: 8.6×FY 2023: -0.8×
FY 2014 5y median 2.8× FY 2023
Interest Coverage -9.8×
FY 2014: -15.9×FY 2015: -10.4×FY 2016: -27.7×FY 2017: -36.5×FY 2018: -15.5×FY 2019: -31.9×FY 2020: -18.9×FY 2021: -7.6×FY 2022: -9.8×FY 2023: -9.8×
FY 2014 5y median -9.8× FY 2023

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2022-11-30